Skip to main content
. 2023 Jun 20;43(6):1035–1040. [Article in Chinese] doi: 10.12122/j.issn.1673-4254.2023.06.21

表 3.

原计划与再计划的剂量学参数比较

Comparison of scores and dosimetric parameters between the original plan (O-P) and the replans (Re-P)

Item Score of O-P Dose of O-P Score ofRe-P Dose ofRe-P
"a" represents significantly difference (P < 0.05); O-P: the original plan Re-P: the re-plans.
PGTV V60Gy(%) 8.58±1.84 94.09±22.80 9.00±0 99.67±0.71
V66Gy(%) 7.68±0.85 0.10±0.27 7.35±1.53 0.24±0.62
D98% (Gy) 4.78±0.76 60.65±1.36 4.89±0.47 61.14±0.77
CI 0.91±0.35 0.46±0.18 0.99±0.28 0.49±0.14
HI 1.86±0.04 0.07±0.02 1.85±0.04 0.07±0.02
GTV Min dose (Gy) 3.79±2.12 59.74±3.63 3.68±2.26 60.21±3.64a
PCTV V45Gy(%) 8.99±0.03 99.19±0.78 8.99±0.03 98.52±0.92a
D98% (Gy) 4.97±0.12 46.03±1.56 4.88±0.22 45.64±1.54a
CI 1.44±0.21 0.72±0.10 1.46±0.18 0.73±0.09
HI 1.22±0.09 0.39±0.05 1.18±0.09a 0.41±0.04a
CTV D98% (Gy) 5.00±0 46.79±1.64 5.00±0 46.76±1.73
Spinal cord Max dose (Gy) 1.62±0.52 33.98±12.24 2.00±0a 28.22±8.85a
Bladder D35% (Gy) 8.65±1.12 46.29±3.13 8.91±1.19a 45.93±3.35a
Rectum D60% (Gy) 3.61±1.49 46.97±1.29 6.37±1.04a 44.47±1.25a
Kidney LV18Gy(%) 4.68±1.15 10.79±17.10 4.92±0.34 7.47±8.54
RV18Gy(%) 4.65±1.15 8.99±11.98 4.91±0.36 8.48±9.06a
Femoral head LD15%(Gy) 1.43±0.71 34.51±7.05 1.84±0.34a 30.76±4.58a
LD1cc (Gy) 0.95±0.12 41.93±4.33 0.96±0.11 42.36±3.44
RD15%(Gy) 1.47±0.72 33.37±7.61 1.78±0.46a 31.56±4.78
RD1cc (Gy) 0.95±0.12 43.04±3.93 0.93±0.15 43.96±3.47
Small intestine V40Gy (cm3) 0.92±0.89 125.39±81.43 1.23±0.78a 96.96±56.76a
V30Gy (cm3) 1.22±0.75 478.42±748.43 1.52±0.67a 252.18±122.00a
Colon V40Gy (cm3) 1.00±0.81 108.72±55.56 1.27±0.67a 94.75±44.51a
V30Gy (cm3) 1.92±0.21 165.12±80.01 1.97±0.14 151.68±68.89a